Company Monitoring Page for Genentech

latest headlines for company on cafepharma

Fresenius Kabi’s Biosimilar for Actemra Gets FDA Approval
BioSpace
Sun, 03/10/24 - 08:25 pm
Tags:
Fresenius Kabi, FDA, biosimilars, Actemra, Tyenne, Genentech
Roche's Genentech spends $15M to rocket into GenEdit’s NanoGalaxy
Fierce Biotech
Tue, 01/23/24 - 10:43 am
Tags:
Roche, Genentech, GenEdit, drug development, gene therapy, autoimmune disease
Roche’s Genentech returns Alzheimer’s assets to AC Immune, cutting 18-year tie to the biotech
Fierce Biotech
Mon, 01/22/24 - 11:19 am
Tags:
Roche, Genentech, AC Immune, Alzheimer's diseasse
Genentech confirms Magargee as permanent CEO
Pharmaphorum
Wed, 12/13/23 - 10:09 pm
Tags:
Roche, Genentech, Pharma CEOs, Ashley Magargee
Genentech's MS drug on partial hold in US after liver enzyme elevations in 2 patients
Fierce Biotech
Mon, 12/4/23 - 06:14 pm
Tags:
Genentech, Roche, MS, multiple sclerosis, fenebrutinib, clinical trials
Roche’s Genentech partners with Nvidia in AI drug deal
BioPharma Dive
Tue, 11/21/23 - 12:00 pm
Tags:
Roche, Genentech, artificial intelligence, NVIDIA
A year after Roche's Alzheimer's failure, scientists reflect on what could have been
Fierce Biotech
Wed, 11/15/23 - 11:49 pm
Tags:
Roche, Genentech, Alzheimer's disease, gantenerumab
BioMarin’s longtime CEO Jean-Jacques Bienaimé hands the reins to Genentech’s Alexander Hardy
Fierce Pharma
Wed, 11/1/23 - 10:20 pm
Tags:
Biomarin, Pharma CEOs, Jean-Jacques Bienaimé, Alexander Hardy, Genentech
FDA Approves Genentech’s Vabysmo for the Treatment of Retinal Vein Occlusion (RVO)
BioSpace
Fri, 10/27/23 - 11:34 am
Tags:
Vabysmo, Genentech, Roche, retinal vein occlusion
Genentech’s Alecensa Reduces the Risk of Disease Recurrence or Death by an Unprecedented 76% in People With ALK-Positive Early-Stage Non-Small Cell Lung Cancer
BioSpace
Wed, 10/18/23 - 10:17 am
Tags:
Genentech, Alecensa, ALK inhibitors, non-small cell lung cancer, ESMO
Majority of Newborn Babies With Spinal Muscular Atrophy (SMA) Treated With Genentech’s Evrysdi Able to Sit Independently After 1 Year of Treatment
BioSpace
Wed, 10/4/23 - 09:41 am
Tags:
Roche, Genentech, clinical trials, Evrysdi, SMA
Roche scores—again—in hemophilia drug patent case against Takeda
Fierce Pharma
Thu, 09/21/23 - 11:47 am
Tags:
Roche, Takeda, patents, legal, Genentech, Baxalta, hemophilia
Genentech sees more potential in peptides, signs $1B biobucks deal with PeptiDream
Fierce Biotech
Wed, 09/20/23 - 08:32 am
Tags:
Genentech, PeptiDream, drug discovery, biobucks, peptides
Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors
BioSpace
Thu, 08/24/23 - 11:50 am
Tags:
Roche, Genentech, divarasib, KRAS inhibitors, solid tumors, clinical trials
FDA Grants Regular Approval of Gavreto for Metastatic NSCLC Subset
Cure Today
Wed, 08/9/23 - 10:42 pm
Tags:
Genentech, Blueprint Medicines, Gavreto, non-small cell lung cancer
Genentech CEO Hardy warns of 'unintended consequences' from the Inflation Reduction Act
Fierce Pharma
Fri, 07/7/23 - 06:57 am
Tags:
Genentech, Pharma CEOs, Alexander Hardy, Inflation Reduction Act
Genentech starting to adopt menopause benefits as they work on recruiting and retaining female employees
Time
Wed, 07/5/23 - 10:39 am
Tags:
Genentech, Women's Health, menopause, employee benefits
Four-Year Follow-Up Data for Genentech’s Evrysdi Show Continued Increase in Number of Children With a Severe Form of Spinal ​Muscular ​Atrophy (SMA)​ Able to Sit, Stand and Walk
BioSpace
Mon, 07/3/23 - 11:38 am
Tags:
Genentech, spinal muscular atrophy, SMA, Evrysdi
After Merck's flashpoint IRA lawsuit, Biogen CEO and others register their own complaints
Fierce Biotech
Wed, 06/7/23 - 10:15 am
Tags:
Merck, Inflation Reduction Act, legal, drug pricing, Biogen, Novartis, Genentech, BIO 2023
Roche looking to sell or shut down California biologic drug plant
Reuters
Thu, 06/1/23 - 11:21 am
Tags:
Roche, Genentech, California, drug manufacturing

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.